Ellipse Technologies, Inc. – Trademark Portfolio
Entity Type: 03
Ellipse Technologies, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 14 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MAGEC, FREEDOM, and PRECICE. The owner is based in Irvine, CA.
13900 Alton Parkway, Suite 123
Irvine, CA 92618
Showing of trademarks Trademarks
Trademark Classifications
Ellipse Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Ellipse Technologies, Inc. have?
Ellipse Technologies, Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 3 registered, 10 abandoned, 1 cancelled.
What trademark classes does Ellipse Technologies, Inc. file in?
Ellipse Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Ellipse Technologies, Inc.'s most well-known trademarks?
Ellipse Technologies, Inc.'s registered trademark portfolio includes well-known marks such as MAGEC, FREEDOM, and PRECICE. These are among 3 currently registered trademarks in the portfolio.
What is Ellipse Technologies, Inc.'s trademark registration success rate?
Ellipse Technologies, Inc. has a 21% trademark registration rate, with 3 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.